Needham analyst Michael Matson has maintained their bullish stance on LIVN stock, giving a Buy rating on October 31. Michael Matson has given ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Other serious implications of sleep apnea and insomnia can impact your heart, diabetes, hypertension and obesity. Read on to understand the healthy sleep positions to adopt to improve your heart and ...

I’m sorry to hear your CPAP mask is keeping you awake at night, but I’m happy to hear that you’re addressing your obstructive ...

Physiological systems in the human body interact throughout life, exhibiting specific patterns during sleep. These networked patterns are present from birth, and are sculpted by varies physiological ...

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

While the solutions for an unhealthy diet and lack of exercise are clear, the solutions for sleep apnea are less clear. There ...

Think of the heart as a pump that works tirelessly every day. But sometimes, this pump starts to weaken, which is what ...

C-reactive protein (CRP) levels may be a biomarker for cardiometabolic risk and insulin resistance among adults with mild to moderate obstructive sleep apnea (OSA) aged less than 60 years, according ...

LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary ...

Bryan Vadney, an Army Veteran used to love life, being active, spending time with family and friends and taking part in his ...

LivaNova (LIVN) “announced that it met the primary endpoints for its OSPREY randomized controlled trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with ...